Abbott Molecular, Inc.: Device Recall

Recall #Z-1749-2025 · 04/28/2025

Class II: Risk

Recall Details

Recall Number
Z-1749-2025
Classification
Class II
Product Type
Device
Recalling Firm
Abbott Molecular, Inc.
Status
Ongoing
Date Initiated
04/28/2025
Location
Des Plaines, IL, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
656 units

Reason for Recall

There were reports of an increase in reactive negative controls and false positive results.

Product Description

Alinity m Resp-4-Plex AMP Kit, List Number 09N79-096, a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) test intended for the simultaneous qualitative detection and differentiation of RNA from SARS-CoV-2, influenza A virus (flu A), influenza B virus (flu B), and/or Respiratory Syncytial Virus (RSV) in anterior nasal or nasopharyngeal swab specimens collected by a healthcare provider (HCP), or in anterior nasal swab specimens that are self-collected at a healthcare location, from individuals suspected by their HCP of respiratory viral infection consistent with COVID-19.

Distribution Pattern

Worldwide - US Nationwide distribution.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.